Siera Talbott

Siera Talbott brings over 15 years of experience in industry and government-funded projects supporting rapid growth in biologic-based therapies. Siera’s roles mostly focus on Project Management, Product Development and Corporate Development. Siera loves creating structure out of chaos, distilling technical requirements into business outcomes and leading high-functioning teams.

Siera holds a Ph.D. in Cancer Cell Biology from West Virginia University (WVU). Her academic research focused primarily on how cancer cells evolve to become chemotherapy resistant. With an extreme fascination of protein signaling networks, Siera further worked on cell survival and toxicity from nanoparticle exposure for the National Institute of Occupational Safety and Health (NIOSH). Siera went on to setup two first-in-kind Bionano laboratories for WVU serving multiple academic departments, government and industry nearby. During this time, Siera also developed the Environmental Health & Safety program used by the School of Engineering.

As Director of Project Management at Argos Therapeutics (Durham, NC), Siera managed all the operational projects for commercial launch of an autologous cell therapy product for Renal Cell Carcinoma. Later, as Head of Product Launch & Operations for a French biotech company (Erytech Pharma, Lyon, FR), Siera led the expansion into the U.S., including the construction and startup of a GMP manufacturing facility in Princeton, N.J. In conjunction with expansion efforts, she has managed Global Supply Chain and Program Management.

As a contractor, Siera provided clients with CMC and operational strategy support to drive forward early stage companies to the next clinical phase. With many favorite things, she enjoys driving efforts focused on risk and change management, scenario planning and decision analysis.